Moreover, cancerous lesions that were positive on preoperative PSMA PET/CT were larger on histopathological examination than PSMA PET/CT-negative PCa manifestations (median 8.0 mm, IQR 6.1–11.50 vs. median 1.4 mm, IQR 0.5–2.3; p < 0.001). This evidence concerns the gene FOLH1 and posterior cortical atrophy.